Visual impairment certification secondary to ARMD in Leeds, 2005–2010: is the incidence falling?
Authors:
- 13 April 2012
- journal article
- Published by Springer Nature in Eye
- Vol. 26 (7) , 933-936
Abstract
Aim Methods Results ConclusionKeywords
This publication has 10 references indexed in Scilit:
- Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical TrialsOphthalmology, 2011
- Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008Eye, 2010
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsBritish Journal of Ophthalmology, 2009
- Leading causes of certification for blindness and partial sight in England & WalesBMC Public Health, 2006
- How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?British Journal of Ophthalmology, 2003
- Incidence of blindness due to diabetic eye disease in Fife 1990-9British Journal of Ophthalmology, 2001
- Is the incidence of registrable age-related macular degeneration increasing?British Journal of Ophthalmology, 1996
- An international classification and grading system for age-related maculopathy and age-related macular degenerationSurvey of Ophthalmology, 1995
- Unrecognised and unregistered visual impairment.British Journal of Ophthalmology, 1994
- Department of Health and Social Security. Reports on Public Health and Medical Subjects. No. 128. The incidence and causes of blindness in England and Wales 1963-68. With an appendix on services available for incipient blindness.1972